BELLUS Health Inc operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares BELLUS Health Inc with three other
pharmaceutical manufacturers in North America:
Ainos Inc
of UNITED STATES
(2020
sales of $16,563.00
),
Kyto Technology and Life Science Inc
of UNITED STATES
($14,150.00
), and
Elixxer Ltd
(16,272.00 Canadian Dollars [US$12,822.66 ]
).
Sales Analysis.
During the second
quarter of 2021, sales at BELLUS Health Inc totalled
C$4,899.32 .
This is a drop of 8.5%
from the C$5,356.84 in sales at the company during the second quarter in 2020.
During the first two
quarters of 2021, sales totalled C$9,976.36 , which is
6.9% lower
than through the first two quarters of 2020.
During the previous 17 quarters, sales at BELLUS Health Inc have fallen vis-à-vis the same quarter in the previous year.
BELLUS Health Inc reported sales of C$20,088.15 (US$15.83 thousand)
for the
year ending
December of 2020.
This
represents
a
sharp
decrease of 42.6%
versus 2019, when the company's sales were C$35,000.00 .